Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by Sorrento Therapeutics, Inc.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Sorrento Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT00804154
First received: December 5, 2008
Last updated: August 27, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)